Skip to main content

Advertisement

SpringerLink
Log in

Practice Parameters for Anal Squamous Neoplasms

  • Practice Parameters
  • Published:
Diseases of the Colon & Rectum

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66.

    Article  PubMed  Google Scholar 

  2. Ryan DP, Mayer RJ. Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol 2000;12:345–52.

    Article  PubMed  CAS  Google Scholar 

  3. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792–800.

    Article  PubMed  CAS  Google Scholar 

  4. Robb BW, Mutch MG. Epidermoid carcinoma of the anal canal. Clin Colon Rectal Surg 2006;19:54–60.

    Article  PubMed  Google Scholar 

  5. Welton LM, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 2004;13:263–75.

    Article  PubMed  Google Scholar 

  6. Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ. Anal canal and perianal epidermoid cancers. J Am Coll Surg 1997;185:495–505.

    Google Scholar 

  7. Anal canal. In: Greene FL, Page DL, Fleming ID, eds, et al. AJCC cancer staging manual. 6th ed. New York: Springer, 2002:125–30.

  8. Nguyen W, Beck DE. Epidermoid carcinoma of the anal canal. Clin Colon Rectal Surg 2002;15:263–70.

    Article  Google Scholar 

  9. Giovanni M, Bardou VJ, Barclay R, et al. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective, multicenter study. Endoscopy 2001;33:231–6.

    Article  Google Scholar 

  10. Trautmann TG, Zuger JH. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 2005 7:309–13.

    Article  PubMed  Google Scholar 

  11. Cotter SE, Grigsby PW, Siegel BA, et al. FDG-PT/CT in the evaluation of anal carcinoma. Int J Rad Oncol Biol Phys 2006;65:720–5.

    Google Scholar 

  12. Cummings BJ, Keane TJ, O’Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Rad Oncol Biol Phys 1991;21:1115–25.

    CAS  Google Scholar 

  13. Arnott SJ, Cunningham JD, Gallagher J, et al. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049–54.

    Article  Google Scholar 

  14. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase 3 randomized intergroup study. J Clin Oncol 1996;14:2527–39.

    PubMed  CAS  Google Scholar 

  15. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of Phase 3 randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040–9.

    PubMed  CAS  Google Scholar 

  16. Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ. Anal canal and perianal epidermoid cancers. J Am Coll Surg 1997;185:494–505.

    PubMed  CAS  Google Scholar 

  17. Ajani JA, Winter KA, Gunderson LL, et al. Intergroup RTOG 98-11: a phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. J Clin Oncol 2006;24:4009.

    Google Scholar 

  18. Constantinou EC, Daly W, Fung CY, et al. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997;39:651–7.

    PubMed  CAS  Google Scholar 

  19. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 1994;73:1569–79.

    Article  PubMed  CAS  Google Scholar 

  20. Graf R, Wust P, Hildebrandt B, et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003;65:14–22.

    Article  PubMed  CAS  Google Scholar 

  21. Deniaud-Alexandre E, Touboul E, Tiret E, et al. Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients. Cancer Radiotherapie 2003;7:237–53.

    PubMed  CAS  Google Scholar 

  22. Renehan AG, Saunders MP, Schofield PF, O’Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 2005;92:605–14.

    Article  PubMed  CAS  Google Scholar 

  23. Das P, Bhatia S, Eng C, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Rad Oncol Biol Phys 2007;68:794–800.

    Google Scholar 

  24. Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002;89:1425–9.

    Article  PubMed  CAS  Google Scholar 

  25. Akbari RP, Paty PB, Guillem JG, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 2004;47:1136–44.

    Article  PubMed  Google Scholar 

  26. Papaconstantinou HT, Bullard KM, Rothenberger DA, Madoff RD. Salvage abdominoperineal resection after failed Nigro protocol: modest success, major morbidity. Colorectal Dis 2006;8:124–9.

    Article  PubMed  CAS  Google Scholar 

  27. Carey RW. Regression of pulmonary metastases from cloacogenic carcinoma after cis-platinum/5-fluorouracil treatment. J Clin Gastroenterol 1984;6:257–9.

    PubMed  CAS  Google Scholar 

  28. Ajani JA, Carrasco CH, Jackson DE, Wallace S. Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med 1989;87:221–4.

    Article  PubMed  CAS  Google Scholar 

  29. Sischy B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally respectable adenocarcinoma of the rectum. Int J Rad Oncol Biol Phys 1985;11:1587–93.

    CAS  Google Scholar 

  30. Golden GT, Horseley JS. Surgical management of epidermoid carcinoma of the anus. Am J Surg 1976;131:275–80.

    Article  PubMed  CAS  Google Scholar 

  31. Quan SH. Anal and perianal tumors. Surg Clin N Am 1978;58:549–603.

    Google Scholar 

  32. Perera D, Pathman-Nathan N, Rabbitt P, Hewett P, Rieger N. Sentinel node biopsy for squamous cell carcinoma of the anus and anal margin. Dis Colon Rectum 2003;46:1027–31.

    Article  PubMed  CAS  Google Scholar 

  33. Melbye M, Cote T, Kessler L, et al. High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 1994;343:636–9.

    Article  PubMed  CAS  Google Scholar 

  34. Hoffman R, Welton M, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Rad Oncol Biol Phys 1999;44:127–31.

    Article  CAS  Google Scholar 

  35. Berry JM, Palefsky JM, Welton ML. Anal cancer and its precursors in HIV–positive patients: perspectives and management. Surg Oncol Clin N Am 2004;13:355–73.

    Article  PubMed  Google Scholar 

  36. Cleator S, Fife K, Nelson M, Gazzard B, Phillips R, Bower M. Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer 2000;36:754–8.

    Article  PubMed  CAS  Google Scholar 

  37. Place RJ, Gregorcyk SG, Huber PJ, Simmang CL. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001;44:506–12.

    Article  PubMed  CAS  Google Scholar 

  38. Papillon J, Mayer M, Montbarbon JF, Gerard JP, Chassard JL, Bailly C. A new approach to the management of epidermoid carcinoma of the anal canal. Cancer 1983;51:1830–7.

    Article  PubMed  CAS  Google Scholar 

  39. Longo WE, Vernava AM, Wade TP, et al. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg 1994;220:40–9.

    Article  PubMed  CAS  Google Scholar 

  40. Herzog U, Boss M, Spichtin H. Endoanal ultrasonography in the follow-up of anal carcinoma. Surg Endosc 1998;8:1186–9.

    Article  Google Scholar 

  41. Christensen AF, Nielsen MB, Svendsen LB, Engelholm SA. Three-dimensional anal endosonography may improve detection of recurrent anal cancer. Dis Colon Rectum 2006;49:1527–32.

    Article  PubMed  Google Scholar 

  42. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg 1976;184:422–8.

    Article  PubMed  CAS  Google Scholar 

  43. Zelnick RS, Haas PA, Ajloun M, et al. Results of abdominoperineal resections for failure after combination chemotherapy and radiation therapy for anal canal cancers. Dis Colon Rectum 1992;35:574–8.

    Article  PubMed  CAS  Google Scholar 

  44. Darragh TM, Winkler B. The ABCs of anal-rectal cytology. College of American Pathologists. Available at: http://www.cap.org/apps/cap.portal. Accessed June 20, 2007.

  45. Palefsky J, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:314–9.

    PubMed  CAS  Google Scholar 

  46. Ogunbiyi OA, Scholefield JH, Raftery AT, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994;81:365–7.

    Article  PubMed  CAS  Google Scholar 

  47. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843–9.

    Article  PubMed  CAS  Google Scholar 

  48. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 2005;97:896–905.

    PubMed  Google Scholar 

  49. Schiffman MH, Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003;95:E2.

    Article  PubMed  Google Scholar 

  50. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:1350–8.

    Article  PubMed  CAS  Google Scholar 

  51. Chang GJ, Welton ML. Anal neoplasia. Sem Colon Rectal Surg 2003;14:111–8.

    Article  Google Scholar 

  52. Palefsky J, Holly E, Ralston M, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:320–6.

    PubMed  CAS  Google Scholar 

  53. Devaraj B, Cosman BC. Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum 2006;49:36–40.

    Article  PubMed  Google Scholar 

  54. Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 2006;76:715–7.

    Article  PubMed  Google Scholar 

  55. Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005;92:1133–6.

    Article  PubMed  CAS  Google Scholar 

  56. Arain S, Walts AE, Thomas P, Bose S. The anal Pap smear: cytomorphology of squamous intraepithelial lesions. CytoJournal 2005;2:4.

    Article  PubMed  Google Scholar 

  57. Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:415–22.

    PubMed  CAS  Google Scholar 

  58. Fox PA, Seet JE, Stebbing J, et al. The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect 2005;81:142–6.

    Article  PubMed  CAS  Google Scholar 

  59. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999;281:1822–9.

    Article  PubMed  CAS  Google Scholar 

  60. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000;108:634–41.

    Article  PubMed  CAS  Google Scholar 

  61. Arbesman H, Ransohoff DF. Is Bowen’s disease a predictor for the development of internal malignancy? A methodological critique of the literature. JAMA 1987;257:516–8.

    Article  PubMed  CAS  Google Scholar 

  62. Wieland U, Brockmeyer NH, Weissenborn SJ, et al. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 2006;142:1438–44.

    Article  PubMed  CAS  Google Scholar 

  63. Wendling J, Saiag P, Berville-Levy S, Bourgault-Villada I, Clerici T, Moyal-Barracco M. Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% imiquimod cream: a prospective study of 12 cases. Arch Dermatol 2004;140:1220–4.

    Article  PubMed  CAS  Google Scholar 

  64. Diakomanolis E, Haidopoulos D, Stefanidis K. Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream. N Engl J Med 2002;347:374.

    Article  PubMed  Google Scholar 

  65. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998;38:230–9.

    Article  PubMed  CAS  Google Scholar 

  66. Moore RA, Edwards JE, Hopwood J, Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001;1:3.

    Article  PubMed  CAS  Google Scholar 

  67. Bargman H, Hochman J. Topical treatment of Bowen’s disease with 5-fluorouracil. J Cutan Med Surg 2003;7:101–5.

    PubMed  Google Scholar 

  68. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen’s disease: 2006 update. Br J Dermatol 2007;156:11–21.

    Article  PubMed  CAS  Google Scholar 

  69. Gonzalez Sanchez JL, Flores Murrieta G, Chavez Brambila J, Deolarte Manzano JM, Andrade Manzano AF. Topical 5-fluorouracil for treatment of vaginal intraepithelial neoplasms. Ginecol Obstet Mex 2002;70:244–7.

    PubMed  Google Scholar 

  70. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 2007;56:125–43.

    Article  PubMed  Google Scholar 

  71. Hamdan KA, Tait IS, Nadeau V, Padgett M, Carey F, Steele RJ. Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon Rectum 2003;46:1555–9.

    Article  PubMed  Google Scholar 

  72. Runfola MA, Weber TK, Rodriguez-Bigas MA, Dougherty TJ, Petrelli NJ. Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum 2000;43:499–502.

    Article  PubMed  CAS  Google Scholar 

  73. Webber J, Fromm D. Photodynamic therapy for carcinoma in situ of the anus. Arch Surg 2004;139:259–61.

    Article  PubMed  CAS  Google Scholar 

  74. Abbasakoor F, Boulos PB. Anal intraepithelial neoplasia. Br J Surg 2005;92:277–90.

    Article  PubMed  CAS  Google Scholar 

  75. Scholefield JH, Ogunbiyi OA, Smith JH, Rogers K, Sharp F. Treatment of anal intraepithelial neoplasia. Br J Surg 1994;81:1238–40.

    Article  PubMed  CAS  Google Scholar 

  76. Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC. Perianal Bowen’s disease: a clinicopathologic study of 47 patients. Dis Colon Rectum 1997;40:1286–93.

    Article  PubMed  CAS  Google Scholar 

  77. Brown SR, Skinner P, Tidy J, Snith JH, Sharp F, Hoise KB. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen’s disease). Br J Surg 1999;86:1063–6.

    Article  PubMed  CAS  Google Scholar 

  78. Pineda CE, Berry JM, Welton ML. High-resolution anoscopy and targeted treatment of high-grade squamous intraepithelial lesions. Dis Colon Rectum 2006;49:126.

    Article  PubMed  Google Scholar 

  79. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002;45:453–8.

    Article  PubMed  Google Scholar 

  80. Goldstone SE, Kawalek AZ, Huyett JW. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum 2005;48:1042–54.

    Article  PubMed  Google Scholar 

  81. Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997;40:919–28.

    Article  PubMed  CAS  Google Scholar 

  82. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002;35:1127–34.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Contributing Members of the ASCRS Standards Committee:

Amir Bastawrous, M.D., Elin Sigurdson, M.D., Ravin Kumar, M.D., Scott Steele, M.D., Raham Newstead, M.D., Scott Strong, M.D., Terry Phang, M.D., Joe Tjandra, M.D.,Paul Shellito, M.D.

Author information

Authors and Affiliations

  1. Fletcher Allen Health Care, 111 Colchester Avenue, Fletcher 301, Burlington, VT, 05401, USA

    Phillip R. Fleshner M.D., Sridhar Chalasani M.D., George J. Chang M.D., David H. Levien M.D., Neil H. Hyman M.D. & W. Donald Buie M.D.

Authors
  1. Phillip R. Fleshner M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sridhar Chalasani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George J. Chang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David H. Levien M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Neil H. Hyman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Donald Buie M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

The Standards Practice Task Force of The American Society of Colon and Rectal Surgeons

Corresponding author

Correspondence to Neil H. Hyman M.D..

Additional information

No reprints available.

Appendix

Appendix

  LEVELS OF EVIDENCE AND GRADE RECOMMENDATION
Full size table

About this article

Cite this article

Fleshner, P.R., Chalasani, S., Chang, G.J. et al. Practice Parameters for Anal Squamous Neoplasms. Dis Colon Rectum 51, 2–9 (2008). https://doi.org/10.1007/s10350-007-9093-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-007-9093-3

Keywords

Search

Navigation